Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$92.3K Buy
255
+250
+5,000% +$85.6K 0.05% 271
2026
Q1
$1.68K Sell
5
-2
-29% -$713 ﹤0.01% 732
2025
Q4
$2.2K Buy
7
+2
+40% +$634 ﹤0.01% 717
2025
Q3
$1.32K Buy
+5
New +$1.45K ﹤0.01% 743
2025
Q1
– Sell
-7
Closed -$1.71K – 160
2024
Q4
$1.71K Buy
7
+1
+17% +$297 ﹤0.01% 676
2024
Q3
$1.96K Hold
6
– – ﹤0.01% 665
2024
Q2
$2.01K Sell
6
-2
-25% -$588 ﹤0.01% 653
2024
Q1
$2.4K Sell
8
-10
-56% -$2.93K ﹤0.01% 661
2023
Q4
$5.09K Buy
+18
New +$4.9K ﹤0.01% 549

Other funds holding AMGN

Caitlin John's AMGN Position: Q2 2026 in Review

Caitlin John increased its Amgen (AMGN) stake by 5,000% in Q2 2026, buying an estimated $85.6K and bringing the position to 255 shares worth $92.3K. The position accounts for 0.05% of the portfolio, ranked #271.

Caitlin John first reported a position in AMGN in Q4 2023 and has held it in 9 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Caitlin John held 255 shares of Amgen worth $92.3K as of Q2 2026.
  • Caitlin John bought 250 Amgen shares in Q2 2026, an estimated $85.6K.
  • Amgen made up 0.05% of Caitlin John's portfolio in Q2 2026, its #271 holding.
  • Caitlin John first reported a position in Amgen in Q4 2023 and has held it in 9 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.